| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/21/2009 | US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 04/21/2009 | US7521478 Antitumor agents; synthetic derivatives equivalent to marine polyketide derived components isolated from bryozoan Myriapora truncata; removing protecting groups from intermediates |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | US20090099169 Benzofuran Compounds As EP1 Receptor Antagonists |
| 04/15/2009 | EP2046758A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/15/2009 | EP1694641B1 Prostaglandin synthesis |
| 04/15/2009 | CN101407512A Preparation of bicyclohexyl neopentyl glycol single ketal |
| 04/15/2009 | CN101407493A Organic material and use thereof in organic EL device |
| 04/15/2009 | CN100478336C Derivative of methyol series of andrographolide C15 |
| 04/14/2009 | CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic |
| 04/09/2009 | WO2009013171A3 Heterocyclic antiviral compounds |
| 04/09/2009 | DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers |
| 04/08/2009 | EP2045247A1 Compounds for the inhibition of histone deacetylase |
| 04/08/2009 | EP2044061A2 Benzothiophene inhibitors of rho kinase |
| 04/08/2009 | EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/08/2009 | EP2043744A2 Chemical compounds |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | CN101405270A Pyrazoles as 11-beta-HSD-1 |
| 04/08/2009 | CN101402623A 3-substituted benzene phthalein compounds with biological activity |
| 04/07/2009 | CA2430814C A process for the preparation of paclitaxel |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/01/2009 | EP2041113A1 Novel pyridazine derivatives |
| 04/01/2009 | EP2040690A1 Inhibitors of cxcr2 |
| 03/31/2009 | US7511150 Including N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide, starting by reacting 4-difluoromethoxy-3-hydroxybenzaldehyde with 2-bromo-1-fluoro-4-nitrobenzene; phosphodiesterase PDE IV inhibitors; anti-inflammatory treatments in airway diseases |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2008126943A3 Method for manufacturing neuraminic acid derivatives |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP1784389A4 Process for atorvastatin calcium amorphous |
| 03/25/2009 | EP1610790A4 Anticancer compounds |
| 03/25/2009 | CN101391996A Method for preparing landiolol intermediate |
| 03/25/2009 | CN100471854C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 03/25/2009 | CN100471845C C 10 ester substituted taxadane |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | US7507395 Include pH-sensitive fluorescent and fluorogenic 2',7'-dialkylfluorescein derivatives and associated nonfluorescent precursor compounds; malignancy, multidrug resistance, lysosome storage disease, corneal acidosis, ulcer disease, diabetic heart condition, or hyperglycemia |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009036144A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009008980A3 Tetrahydropyranochromene gamma secretase inhibitors |
| 03/19/2009 | US20090076128 Deuterium-enriched topiramate |
| 03/19/2009 | CA2699384A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/18/2009 | EP2035371A2 Substituted phenyl methanone derivatives |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 03/17/2009 | US7504434 3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-dimer; viricide; influenza A or B infection, parainfluenza, mumps or Newcastle disease, myxovirus infections; stability; long time in lungs |
| 03/17/2009 | US7504391 Analogues of N-methyl, hydroxy(alkoxy)-partially saturated indeno(1,2-a)-3-benzoazeines, naphtho(1,2-a)-3-benzoazepines, and 1-phenyl-3-benzazepenes; metabolic disorders/eating disorders, e.g., obesity (dietetics), hyperphagia; antidiabetic agents; obsessive compulsive, somatoform dissociative disorders |
| 03/12/2009 | WO2009031999A1 Fr901464 and analogs with antitumor activity and method for their preparation |
| 03/12/2009 | US20090069357 Deuterium-enriched iclaprim |
| 03/12/2009 | US20090069316 Novel quinoline derivatives |
| 03/12/2009 | US20090069252 C-glycoside derivatives and salts thereof |
| 03/12/2009 | US20090068379 Dioxetane compound, cationically polymerizable composition, optical film, and liquid crystal display device |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases |
| 03/11/2009 | CN101381363A Method for extracting macroporous adsorption resin and separating hepadestal from alkaline water |
| 03/05/2009 | WO2009029625A1 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009026961A1 Processes for the preparation of pancratistatin and pancratistatin analogues |
| 03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
| 03/05/2009 | US20090062554 Process for preparing phosphorus compounds having phosphate-phosphonate bond |
| 03/05/2009 | US20090062365 Pyrazoles for the Treatment of GERD and IBS |
| 03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |
| 03/05/2009 | US20090062348 Antifungal Agent Containing Pyridine Derivative |
| 03/05/2009 | US20090058289 Materials for Organic Electroluminescent Devices |
| 03/04/2009 | CN101379058A Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
| 03/04/2009 | CN101376654A Water-soluble aminoacid ester derivative of silibinin |
| 03/04/2009 | CN100465173C A selective kinase inhibitor |
| 03/03/2009 | US7498450 Hydrogenation of dicarboxylic acids to form diols, cyclic ethers and lactones in the presence of an aqueous solution of a ruthenium, rhodium, iron, osmium or palladium compound and a phosphine, preferably tridentate facially capped phosphines (tris-1,1,1-(diarylphosphinomethyl)alkane) |
| 02/26/2009 | US20090054668 Protease inhibitor precursor synthesis |
| 02/26/2009 | US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 02/26/2009 | US20090054357 Macrolide compounds endowed with antiinflammatory activity |
| 02/25/2009 | EP2027115A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof |
| 02/25/2009 | EP2027091A1 New pharmaceutical compounds |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495027 drugs that inhibit biosynthesis of bacterial cell walls, such as (5Z)-5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one, used for treatment of bacterial infections, and as parasiticides |
| 02/19/2009 | WO2009023196A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 02/19/2009 | WO2009022171A1 Pyridinyiioxy pyridines as alk5 inhibitors |
| 02/19/2009 | WO2009021980A1 α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS |
| 02/19/2009 | WO2009021948A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | WO2009021947A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 02/19/2009 | US20090048457 Process for preparation of racemic nebivolol |
| 02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090047224 Cosmetic Process for Preventing or Treating the Signs of Skin Ageing or the Orange-Peel Appearance |
| 02/19/2009 | CA2733706A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024336A1 Novel pharmaceutical compositions |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | CN101370798A Novel compounds for forming taxone, method and use thereof |